CryoLife Reports Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Piper Jaffray Remains Bullish on CryoLife (CRY) Following 2Q Report
July 26, 2016 7:54 AM EDTPiper Jaffray reiterated an Overweight rating and $16.00 price target on CryoLife (NYSE: CRY) following the company's 2Q earnings report. CRY reported revenue of $47.1M, driven by recently acquired On-X, improvements to the vascular tissue business, and strong BioGlue sales. Adjusted cash EPS of $0.13 beat the consensus of $0.07.... More
CryoLife (CRY) Reports Q2 EPS of $0.07
July 25, 2016 5:36 PM EDTCryoLife (NYSE: CRY) reported Q2 EPS of $0.07, versus ($0.02) reported last year. Revenue for the quarter came in at $47.1 million, versus $35.5 million reported last year.
GUIDANCE:
CryoLife sees Q3 2016 EPS of $0.32-$0.32, versus prior guidance of $0.29-$0.32. CryoLife sees Q3 2016... More
